Join the Constipation group to help and get support from people like you.
Constipation News
Related terms: Difficulty passing stool, Irregularity of bowels
Mind, Body Symptoms Can Precede MS Diagnosis for Years
WEDNESDAY, Dec. 6, 2023 – Patients in the earliest stages of multiple sclerosis might develop certain symptoms that offer an early clue to the degenerative nerve disease, researchers report....
Constipation May Be a Marker for Dementia Risk
WEDNESDAY, July 19, 2023 – Chronic constipation may not only be an indicator of gut health, but a potential warning sign of thinking declines, a preliminary study suggests. Researchers found that...
FDA Approves Linzess to Treat Constipation in Children, Teens
WEDNESDAY, June 14, 2023 – The U.S. Food and Drug Administration approved Linzess (linaclotide) as a once-daily treatment for pediatric patients ages 6 to 17 years with functional constipation. The...
Ironwood Pharmaceuticals Announces FDA Approval of New Indication for Linzess (linaclotide) for the Treatment of Functional Constipation in Pediatric Patients Ages 6-17 Years-Old
BOSTON--(BUSINESS WIRE) June 12, 2023 – Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has approved...
Guidelines Developed for Treating Chronic Idiopathic Constipation
THURSDAY, May 25, 2023 – In a clinical practice guideline issued by the American Gastroenterological Association and the American College of Gastroenterology, and published online May 19 in the...
FDA Medwatch Alert: Vi-Jon, LLC Expands Voluntary Nationwide Recall of Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor Due to Microbial Contamination
July 14, 2022 – Smyrna, TN, Vi-Jon, LLC is expanding its voluntary recall to include all lots of Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor, 10 FL OZ (296 mL) within expiry to the c...
FDA Medwatch Alert: Vi-Jon, LLC Issues Voluntary Nationwide Recall of CVS Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor Due to Microbial Contamination
June 21, 2022 - Smyrna, TN, Vi-Jon, LLC is voluntarily recalling 1 (one) lot of CVS Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor, 10 FL OZ (296 mL) to the consumer level. Testing...
FDA Approves Pizensy (lactitol) for the Treatment of Chronic Idiopathic Constipation in Adults
Braintree, Mass. March 02, 2020 -- Sebela Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved Pizensy (lactitol) for oral solution for the once-daily ...
FDA Approves Motegrity (prucalopride) for Adults with Chronic Idiopathic Constipation (CIC)
Cambridge, Mass. – December 17, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) has announced that the U.S. Food and Drug Administration (FDA) has approved Motegrity™ (prucalopride), a once-daily, oral trea...
Synergy Pharmaceuticals Announces FDA Approval of Trulance (plecanatide) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults
NEW YORK--(BUSINESS WIRE) January 25, 2018 – Synergy Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Trulance (plecanatide) 3 mg tablet for the...
FDA Medwatch Alert: Liquid Drug Products Manufactured by PharmaTech and Distributed by Rugby Laboratories and Possibly Other Companies: FDA Advisory - Not to Use
ISSUE: FDA is advising health care professionals and patients not to use any liquid product manufactured by PharmaTech LLC, Davie, Florida, due to Burkholderia cepacia contamination and the potential...
FDA Medwatch Alert: Diocto Liquid and Diocto Syrup by Rugby Laboratories: Recall - Possible Product Contamination
[Posted 08/03/2017] ISSUE: Rugby Laboratories is voluntarily recalling all lots of Diocto Liquid and Diocto Syrup, (docusate sodium solutions) manufactured by PharmaTech, LLC due to a risk of...
FDA Approves Symproic (naldemedine) for the Treatment of Opioid-Induced Constipation
OSAKA, Japan and FLORHAM PARK, N.J. and STAMFORD, Conn., March 23, 2017 /PRNewswire/ – Shionogi Inc. and Purdue Pharma L.P. announced today that the U.S. Food and Drug Administration (FDA) approved...
U.S. FDA Approves 72 mcg Dose of Linzess (linaclotide) for Adults with Chronic Idiopathic Constipation
CAMBRIDGE, Mass. and DUBLIN, Jan. 26, 2017 /PRNewswire/ – Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Allergan plc (NYSE: AGN) announced today that the U.S. Food and Drug Administration (FDA)...
FDA Approves Trulance (plecanatide) for Chronic Idiopathic Constipation
January 19, 2017 – The U.S. Food and Drug Administration today approved Trulance (plecanatide) for the treatment of Chronic Idiopathic Constipation (CIC) in adult patients. “No one medication works f...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Constipation - Chronic, Constipation - Acute, Gastrointestinal Disorders
Related drug support groups
Peri-DS, MiraLax, magnesium citrate, Dulcolax, Metamucil, lactulose, Fleet Enema, Colace, Milk of Magnesia, bisacodyl